Literature DB >> 8680731

Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.

Q Li1, L Zhang, M Pfaffendorf, P A van Zwieten.   

Abstract

1. In the present study, the contractile effects of angiotensin III (AIII) and angiotensin IV (AIV) compared with those of angiotensin II (AII) were determined in rat aortic ring preparations. 2. All three peptides caused concentration-dependent contractions with similar maximal responses. AIII proved approximately 4 times less potent than AII, whereas AIV was about 1000 times less active than AII. 3. The selective AT1-receptor antagonist, losartan (10-300 nM) caused parallel rightward shifts of the concentration-response curves (CRC) for all three peptides. The Schild plot slopes for the effect of losartan on AIII curves were significantly lower than unity (P < 0.05). The selective AT2-receptor antagonist, PD123177 did not influence the CRCs for AII and AIV. However, the AIII curves were moderately shifted leftward in the presence of PD123177 (0.1 and 1 microM). 4. Destruction of the endothelium or incubation with the NO-synthesis inhibitor NG-monomethyl-L-arginine acetate (L-NMMA) (0.1 mM) significantly enhanced the contractile responses to all three peptides. 5. Tachyphylaxis was investigated by constructing a second CRC for all three peptides, after an interval of 1 h. The presence of endothelium significantly enhanced the development of tachyphylaxis to all three peptides. However, in endothelium-denuded preparations, the Emax value of the second curve elicited by AII was about 50%, compared with the first one, whereas for AIII and AIV Emax values were as high as 90% and 100%, respectively. 6. Our results indicate that both AIII and AIV are less potent but similarly efficacious vasoconstrictor agents compared with AII. Their contractile effects are also mediated by AT1-receptors and probably modulated by endothelium. Tachyphylaxis induced by AIII and AIV proved weaker than that for AII. Tachyphylaxis appears to be enhanced by the presence of an intact endothelium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8680731      PMCID: PMC1909200          DOI: 10.1111/j.1476-5381.1995.tb15951.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

Review 1.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels.

Authors:  C A Gruetter; E T Ryan; S M Lemke; D A Bailly; M K Fox; D D Schoepp
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

3.  Central angiotensin IV binding sites: distribution and specificity in guinea pig brain.

Authors:  A V Miller-Wing; J M Hanesworth; M F Sardinia; K L Hall; J W Wright; R C Speth; K L Grove; J W Harding
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

4.  Regional and species differences in the response of isolated arteries to angiotnesin II.

Authors:  N Toda; M Miyazaki
Journal:  Jpn J Pharmacol       Date:  1978-06

5.  Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat.

Authors:  J A Oliver; R R Sciacca
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon.

Authors:  J T Fitzsimons
Journal:  J Physiol       Date:  1971-04       Impact factor: 5.182

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

8.  A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine).

Authors:  A F Moore; M M HAll; P A Khairallah
Journal:  Eur J Pharmacol       Date:  1976-09       Impact factor: 4.432

9.  Endothelium enhances tachyphylaxis to angiotensins II and III in rat aorta.

Authors:  C A Gruetter; E T Ryan; D D Schoepp
Journal:  Eur J Pharmacol       Date:  1987-11-03       Impact factor: 4.432

10.  Central effects of angiotensins on drinking and blood pressure: structure-activity relationships.

Authors:  J A Tonnaer; V M Wiegant; W de Jong; D De Wied
Journal:  Brain Res       Date:  1982-03-25       Impact factor: 3.252

View more
  4 in total

1.  Vasoconstriction is determined by interstitial rather than circulating angiotensin II.

Authors:  Martin P Schuijt; René de Vries; Pramod R Saxena; Maarten A D H Schalekamp; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues.

Authors:  S L Cox; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

3.  Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.

Authors:  Kenji Oki; Phillip G Kopf; William B Campbell; Milay Luis Lam; Takeshi Yamazaki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

4.  Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.

Authors:  Q Li; J Zhang; M Pfaffendorf; P A van Zwieten
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.